CALR and myeloproliferative neoplasm: Recently, Milosevic-Feenstra et al. documented a higher PD-L1 mRNA expression in granulocytes in both JAK2V617F positive ET and primary myelofibrosis (PMF) patients, compared to CALR-mutated MPN patients.